Advanced Search
Published: Sep 5, 2017 DOI: 10.21769/BioProtoc.2537 Views: 12319
Reviewed by: Alessandro Didonna
Abstract
The transcription factor Hypoxia-Inducible Factor (HIF) complexes with the coactivator p300, activating the hypoxia response pathway and allowing tumors to grow. The CH1 and CAD domains of each respective protein form the interface between p300 and HIF. Small molecule compounds are in development that target and inhibit HIF/p300 complex formation, with the goal of reducing tumor growth. High resolution NMR spectroscopy is necessary to study ligand interaction with p300-CH1, and purifying high quantities of properly folded p300-CH1 is needed for pursuing structural and biophysical studies. p300-CH1 has 3 zinc fingers and 9 cysteine residues, posing challenges associated with reagent compatibility and protein oxidation. A protocol has been developed to overcome such issues by incorporating zinc during expression and streamlining the purification time, resulting in a high yield of optimally folded protein (120 mg per 4 L expression media) that is suitable for structural NMR studies. The structural integrity of the final recombinant p300-CH1 has been verified to be optimal using one-dimensional 1H NMR spectroscopy and circular dichroism. This protocol is applicable for the purification of other zinc finger containing proteins.
Keywords: p300Background
The growth of solid tumors is associated with the development of hypoxic areas due to inappropriate vascular irrigation. In response to a hypoxic microenvironment, tumor cells overexpress Hypoxia Inducible Factors (HIF), a family of heterodimeric transcription factors (Semenza, 2002; Brat and Van Meir, 2004; Kaur et al., 2005). HIFs bind to p300, a transcriptional coactivator, to form a complex that induces HIF target genes, thereby activating the hypoxia response pathway and promoting tumor growth (Kasper and Brindle, 2006; Liu, 2008). The binding domains involved with the HIF/p300 protein-protein interface are the cysteine-histidine-rich region 1 (CH1) domain of p300 and the C-terminal activating domain (CAD) of HIF-1α (Dames et al., 2002; Freedman et al., 2002). The hypoxia response pathway facilitates tumor growth under oxygen limiting conditions. Inhibiting this pathway is a goal for targeted anti-cancer therapy (Post et al., 2004; Belozerov and Van Meir, 2006; Mooring, 2011; Tan et al., 2011; Mun et al., 2012; Wilkins et al., 2016). Small molecule compounds have recently been developed to bind to p300-CH1 and inhibit p300/HIF complexation, inhibiting the hypoxia response pathway and reducing tumor growth (Shi et al., 2012; Yin et al., 2012; Burroughs et al., 2013). Furthermore, the p300-CH1 domain has been reported to interact with over 30 additional transcription factors related to cancer and other diseases (Kasper and Brindle, 2006).
This protocol has been developed to purify the p300-CH1 peptide with the purity and structural integrity necessary to conduct structural NMR studies for studying protein-protein and protein-ligand interactions. p300-CH1 poses many challenges for recombinant protein purification, as it contains three zinc fingers and 9 total cysteine residues. p300-CH1 has been reported to be structurally compromised without a 3:1 stoichiometric ratio of zinc (De Guzman et al., 2005). Without zinc, cysteine residues typically found at zinc fingers can form unwanted disulfide linkages that are thermodynamically more stable than cysteine-zinc interactions. Proteins without zinc cations occupying their native zinc fingers are prone to oxidation and readily form disulfide linkages, resulting in unwanted protein conformations and protein aggregation.
Introducing zinc (II) to a protein purification protocol is complicated by the fact that zinc (II) interacts with certain buffer salts, reducing agents, and hydroxide ions to form precipitates. Unwanted zinc (II) precipitation can prevent the formation of crucial zinc fingers and even leach out existing zinc fingers to denature the protein. In addition, the reducing agents and buffer salts that precipitate with zinc may be unavailable to serve their respective purposes for the purification. Zinc (II) cations form white ZnOH precipitates with neutral to alkaline buffer conditions (pH 7.0 and above). Zinc (II) also forms precipitates with phosphate buffer and thiol reducing agents (BME and DTT). The buffers and reagents used for the purification procedure must be carefully selected to be compatible with zinc. As a precaution, zinc stocks and zinc containing solutions must be pH adjusted with zinc present to verify that ZnOH precipitates do not form during purification. This is especially important in purifying high yields of properly folded zinc-finger containing proteins.
The purification protocol has been designed with the following strategies to minimize oxidation and maximize yield:
1. Occupy cysteine residues with zinc (II) throughout the protocol
2. Streamline the duration of expression and cleavage
3. Use reducing agents whenever possible
The protocol successfully overcomes issues of reagent compatibility and oxidation, yielding 120 mg of purified recombinant p300-CH1 from a 4 L bacterial culture. Concentration of recombinant p300-CH1 was measured by UV-Vis absorbance at a wavelength of 280 nm. The extinction coefficient of p300-CH1 is calculated to be 5,690 L mol-1 cm-1 by ExPASy ProtParam tool (Shi et al., 2012). According to circular dichroism and 1H NMR, the purified p300-CH1 recombinant protein product is optimally folded without the need for any further modification post-purification. The protocol and its strategies can be applied to other cysteine containing proteins systems to improve yield and purity.
Materials and Reagents
Equipment
Procedure
Category
Cancer Biology > Cancer biochemistry > Protein
Biochemistry > Protein > Isolation and purification
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Share
Bluesky
X
Copy link